Royalty Pharma plc SEC filings RPRX
Royalty Pharma plc has 635 filings in SEC EDGAR's recent list, going back to Feb 13, 2020. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 13F-NT | Filing | Aug 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
May 28, 2026 | May 22, 2026 |
| 13F-NT | Filing | May 14, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 13, 2026 | Apr 13, 2026 |
| ARS | Annual report to shareholders | Apr 10, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 10, 2026 | — |
| DEF 14A | Proxy statement | Apr 10, 2026 | Jun 4, 2026 |
| 13F-NT | Filing | Apr 1, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Feb 11, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 22, 2025 | Dec 20, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 22, 2025 | Dec 19, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 16, 2025 | Sep 16, 2025 |
| 424B2 | Prospectus | Sep 3, 2025 | — |
| FWP | Free writing prospectus | Sep 3, 2025 | — |
| 424B2 | Prospectus | Sep 2, 2025 | — |
| POSASR | Filing | Sep 2, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Aug 13, 2025 | Aug 13, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 17, 2025 | Jul 17, 2025 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Officer or director change, Bylaw or fiscal year change
|
May 19, 2025 | May 16, 2025 |
| S-8 | Employee stock plan registration | May 16, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
May 12, 2025 | May 12, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| DEFA14A | Additional proxy material | Apr 11, 2025 | — |
| 8-K |
Current report
Material agreement
|
Apr 11, 2025 | Apr 11, 2025 |
| ARS | Annual report to shareholders | Apr 11, 2025 | Dec 31, 2024 |
| DEFM14A | Filing | Apr 11, 2025 | — |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Apr 10, 2025 | Apr 7, 2025 |
| UPLOAD | Letter from the SEC | Apr 9, 2025 | — |
| CORRESP | Letter to the SEC | Apr 4, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 28, 2025 | — |
| DEFA14A | Additional proxy material | Mar 5, 2025 | — |
| PREM14A | Prem 14a | Feb 13, 2025 | Feb 12, 2025 |
| 10-K | Annual report | Feb 12, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 11, 2025 | Feb 11, 2025 |
| DEFA14A | Additional proxy material | Jan 17, 2025 | — |
| DEFA14A | Additional proxy material | Jan 16, 2025 | — |
| 425 | Form 425 | Jan 15, 2025 | — |
| DEFA14A | Additional proxy material | Jan 13, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| DEFA14A | Additional proxy material | Jan 10, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Material agreement, Bylaw or fiscal year change
|
Dec 31, 2024 | Dec 31, 2024 |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 27, 2024 | Sep 26, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 7, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Other events
|
Jun 20, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 10, 2024 | Jun 10, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 6, 2024 |
| 424B5 | Prospectus supplement | Jun 4, 2024 | — |
| 8-K |
Current report
Material agreement
|
Jun 4, 2024 | Jun 3, 2024 |
| FWP | Free writing prospectus | Jun 3, 2024 | — |
| 424B5 | Prospectus supplement | Jun 3, 2024 | — |
| S-3ASR | Automatic shelf registration | Jun 3, 2024 | — |
| 8-K |
Current report
Other events
|
May 29, 2024 | May 29, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 6, 2024 |
| 10-K | Annual report | Feb 15, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 15, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Other events
|
Feb 6, 2024 | Feb 5, 2024 |
| UPLOAD | Letter from the SEC | Jan 30, 2024 | — |
| CORRESP | Letter to the SEC | Jan 24, 2024 | — |
| 8-K |
Current report
Results of operations
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Dec 27, 2023 | Dec 22, 2023 |
| 8-K |
Current report
Other events
|
Dec 27, 2023 | Dec 27, 2023 |
| CORRESP | Letter to the SEC | Dec 11, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 27, 2023 | — |
| 8-K |
Current report
Other events
|
Nov 16, 2023 | Nov 16, 2023 |
| 424B3 | Prospectus | Nov 16, 2023 | — |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
New debt
|
Oct 19, 2023 | Oct 18, 2023 |
| CORRESP | Letter to the SEC | Sep 19, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2023 | — |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| CORRESP | Letter to the SEC | Jul 13, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2023 | Jun 22, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| DEFA14A | Additional proxy material | Apr 27, 2023 | — |
| DEF 14A | Proxy statement | Apr 27, 2023 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 28, 2023 | Mar 24, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 15, 2023 | Mar 15, 2023 |
| 10-K | Annual report | Feb 15, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 15, 2023 | Feb 15, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Impairment
|
Dec 1, 2022 | Dec 1, 2022 |
| APP ORDR | Filing | Nov 22, 2022 | — |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| APP NTC | Filing | Nov 1, 2022 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 3, 2022 | Sep 30, 2022 |
| 40-APP | Form 40-app | Sep 20, 2022 | — |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 8-K |
Current report
Other events
|
Jul 13, 2022 | Jul 13, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2022 | Jun 23, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
May 17, 2022 | May 17, 2022 |
| 8-K |
Current report
Other events
|
May 11, 2022 | May 10, 2022 |
| 10-Q | Quarterly report | May 5, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 5, 2022 | May 5, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 23, 2022 |
| 8-K |
Current report
Other events
|
Apr 15, 2022 | Apr 15, 2022 |
| 424B3 | Prospectus | Apr 15, 2022 | — |
| 8-K |
Current report
Auditor change
|
Apr 4, 2022 | Apr 1, 2022 |
| 10-K | Annual report | Feb 15, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 15, 2022 | Feb 15, 2022 |
| 8-K |
Current report
Results of operations
|
Jan 10, 2022 | Jan 10, 2022 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 10-Q | Quarterly report | Aug 11, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2021 | Aug 11, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 26, 2021 | Jul 26, 2021 |
| 424B5 | Prospectus supplement | Jul 19, 2021 | — |
| 8-K |
Current report
Material agreement
|
Jul 16, 2021 | Jul 15, 2021 |
| FWP | Free writing prospectus | Jul 15, 2021 | — |
| 424B5 | Prospectus supplement | Jul 15, 2021 | — |
| S-3ASR | Automatic shelf registration | Jul 14, 2021 | — |
| EFFECT | Filing | Jul 7, 2021 | — |
| 424B3 | Prospectus | Jul 7, 2021 | — |
| S-4/A | Filing | Jul 2, 2021 | — |
| CORRESP | Letter to the SEC | Jul 1, 2021 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2021 | Jun 24, 2021 |
| UPLOAD | Letter from the SEC | Jun 25, 2021 | — |
| S-4 | Registration for a merger or exchange | Jun 21, 2021 | — |
| 8-K |
Current report
Other events
|
Jun 2, 2021 | Jun 2, 2021 |
| 10-Q | Quarterly report | May 11, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 11, 2021 | May 11, 2021 |
| DEFA14A | Additional proxy material | Apr 29, 2021 | — |
| DEF 14A | Proxy statement | Apr 29, 2021 | Jun 24, 2021 |
| 10-K | Annual report | Feb 24, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 17, 2021 | Feb 17, 2021 |
| 8-K |
Current report
Other events
|
Feb 3, 2021 | Feb 3, 2021 |
| 10-Q | Quarterly report | Nov 12, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2020 | Nov 10, 2020 |
| 8-K |
Current report
Material agreement
|
Nov 5, 2020 | Oct 30, 2020 |
| 424B4 | Prospectus | Oct 19, 2020 | — |
| EFFECT | Filing | Oct 15, 2020 | — |
| CORRESP | Letter to the SEC | Oct 13, 2020 | — |
| CORRESP | Letter to the SEC | Oct 13, 2020 | — |
| S-1 | Registration statement | Oct 13, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2020 | — |
| DRS | Filing | Sep 29, 2020 | — |
| 8-K |
Current report
Material agreement, New debt
|
Sep 2, 2020 | Sep 2, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 19, 2020 | Aug 19, 2020 |
| 10-Q | Quarterly report | Aug 12, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2020 | Aug 12, 2020 |
| 8-K/A |
Amended current report
Officer or director change
|
Aug 3, 2020 | Jul 30, 2020 |
| 8-K |
Current report
Officer or director change
|
Aug 3, 2020 | Jul 30, 2020 |
| 8-K |
Current report
Results of operations
|
Jul 14, 2020 | Jul 14, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Other events
|
Jun 19, 2020 | Jun 16, 2020 |
| 424B4 | Prospectus | Jun 17, 2020 | — |
| SEC STAFF LETTER | Filing | Jun 15, 2020 | — |
| EFFECT | Filing | Jun 15, 2020 | — |
| S-1MEF | Filing | Jun 15, 2020 | — |
| S-8 | Employee stock plan registration | Jun 15, 2020 | — |
| CERT | Filing | Jun 15, 2020 | — |
| 8-A12B | Filing | Jun 15, 2020 | — |
| CORRESP | Letter to the SEC | Jun 11, 2020 | — |
| CORRESP | Letter to the SEC | Jun 11, 2020 | — |
| CORRESP | Letter to the SEC | Jun 11, 2020 | — |
| S-1/A | Amended registration statement | Jun 11, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 9, 2020 | — |
| S-1/A | Amended registration statement | Jun 8, 2020 | — |
| SEC STAFF LETTER | Filing | Jun 5, 2020 | — |
| S-1/A | Amended registration statement | Jun 2, 2020 | — |
| S-1 | Registration statement | May 22, 2020 | — |
| DRS/A | Filing | May 19, 2020 | — |
| DRS/A | Filing | May 18, 2020 | — |
| DRSLTR | Filing | May 15, 2020 | — |
| UPLOAD | Letter from the SEC | May 8, 2020 | — |
| DRS/A | Filing | Apr 23, 2020 | — |
| DRSLTR | Filing | Apr 22, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2020 | — |
| DRS/A | Filing | Mar 27, 2020 | — |
| DRSLTR | Filing | Mar 26, 2020 | — |
| UPLOAD | Letter from the SEC | Mar 12, 2020 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RPRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1802768
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.